GlassScriptPhysician profile
Bradley Foster
NPI 1801882667
$10,496.31
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $123 · 2021: $201 · 2022: $201 · 2023: $762 · 2024: $9,032.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,150 · Travel and Lodging: $1,571 · Food and Beverage: $1,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,150.00 |
| Travel and Lodging | $1,571.09 |
| Food and Beverage | $1,072.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $9,172.47 | 2023-2024 | Constellation, Clareon, Lensx |
| Novartis Pharmaceuticals Corporation | $270.78 | 2019-2020 | |
| Genentech USA, INC. | $242.24 | 2021-2024 | Vabysmo |
| Glaukos Corporation | $220.20 | 2023 | Radius Xr, Photrexa Cross-Linking Kit, Istent Inject Trabecular Micro-Bypass System |
| Regeneron Healthcare Solutions, INC. | $168.54 | 2021-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $139.71 | 2023 | Tecnis Iol, Tecnis Simplicity, Tecnis Iol |
| Rxsight INC | $138.55 | 2023 | Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Handpiece |
| Astellas Pharma US INC | $52.48 | 2023-2024 | Izervay |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $29.95 | 2019-2020 | |
| Optovue, INC. | $21.86 | 2021 | |
| Apellis Pharmaceuticals, INC. | $21.13 | 2024 | Syfovre |
| Bausch & Lomb Americas INC. | $18.40 | 2023 | Xipere |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.